|
|
Volumn 366, Issue 25, 2012, Pages 2425-2426
|
|
Effect of a monoclonal antibody to PCSK9 on LDL cholesterol [1]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD81 ANTIGEN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN RECEPTOR;
MONOCLONAL ANTIBODY;
PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9;
REGN 727;
SAR 236553;
SERINE PROTEINASE;
UNCLASSIFIED DRUG;
HYPOCHOLESTEROLEMIC AGENT;
ANTIGEN EXPRESSION;
DRUG SAFETY;
FAMILIAL HYPERCHOLESTEROLEMIA;
HEPATITIS C;
HIGH RISK POPULATION;
HUMAN;
INFECTION SENSITIVITY;
LETTER;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN DEGRADATION;
PROTEIN FUNCTION;
RECEPTOR DOWN REGULATION;
RECEPTOR UPREGULATION;
VIRUS ENTRY;
BLOOD;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
HYPERCHOLESTEROLEMIA;
MALE;
NOTE;
ANTIBODIES, MONOCLONAL;
ANTICHOLESTEREMIC AGENTS;
CHOLESTEROL, LDL;
FEMALE;
HUMANS;
HYPERCHOLESTEROLEMIA;
MALE;
PROPROTEIN CONVERTASES;
RECEPTORS, LDL;
|
|
EID: 84862554538
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1204929 Document Type: Letter |
|
Times cited : (5)
|
|
References (4)
|
